Derived from Strategic Transactions, Informa's premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced June through July 2016.

Employers and PBMs are defining a second generation strategies to reduce drug and related medical costs, at a time when pharmaceutical companies are questioning whether PBM’s first generation delivered on its promises.